Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
Étude PARSIFAL - MedOPP067 : étude de phase 2, randomisée, comparant l’efficacité et la tolérance d'un traitement par palbociclib associé au fulvestrant ou au letrozol chez des patientes ayant un cancer du sein métastatique, HER2-, ER+. https://kusajili.fr:443/Trial/vXRkKkpaW0SZztIqCrtGmg%24etude-parsifal---medopp067-etude-de-phase-2-randomisee-comparant-lefficacite-et-la-tolerance-dun-traitement-par-palbociclib-ass
I have read and accept the terms of use of the site and the Privacy Policy
Send your message